Difference between revisions of "3M Pharmaceuticals"
(removed PhRMA affiliation - ref not found) |
(reinstating affiliations) |
||
| Line 4: | Line 4: | ||
==Affiliations== | ==Affiliations== | ||
| − | + | 3M Pharmaceuticals is listed as a member of the [[Pharmaceutical Research and Manufacturers of America]] (PHRMA) in 2005<ref> PHRMA [http://www.phrma.org/2005_industry_profile/12/ 2005 Industry Profile] Accessed 16th December 2007</ref> and 2006 <ref> PHRMA 2006 [http://web.archive.org/web/20060622190420/http://www.phrma.org/about_phrma/member_company_list/members/ Member Company List] Accessed 16th December 2007</ref>. | |
==References== | ==References== | ||
Revision as of 11:38, 16 December 2007
In the latter part of 2006, Meda announced completion its acquisition of the pharmaceutical division of 3M in Europe. [1]
At the same time, 3M announced that it had agreed to sell its pharmaceutical operations in the United States, Canada, and Latin America region to Graceway Pharmaceuticals Inc. at a cost of $875million. 3M's pharmaceutical operations in the Asia Pacific region (including Australia and South Africa) were also sold to Ironbridge Capital and Archer Capital. [2]
Affiliations
3M Pharmaceuticals is listed as a member of the Pharmaceutical Research and Manufacturers of America (PHRMA) in 2005[3] and 2006 [4].
References
- ↑ Zenopa Meda completes 3M Pharmaceuticals acquisition in Europe Eccessed 15th December 2007
- ↑ 3M 3M Reaches Agreements to Sell its Pharmaceuticals Business Accessed 15th December 2007
- ↑ PHRMA 2005 Industry Profile Accessed 16th December 2007
- ↑ PHRMA 2006 Member Company List Accessed 16th December 2007
